Cardiac Research: Absorb III

Clinical Evaluation of the Absorb™ Bioresorbable Vascular Scaffold (BVS) System in the Treatment of Subjects with de novo Native Coronary Artery Lesions

Objective

The purpose of this study is to  find out about the safety and how effective it
is to treat blockages in the coronary (heart) arteries (blood vessels) with
an investigational (experimental) device called Absorb™ Bioresorbable Vascular
Scaffold (BVS) System (the “Absorb BVS”),  as compared to a commercially approved metallic medicated stent called “XIENCE.”
   




   



Principal Investigator(s)
Nicholas Shammas

Clinical Trial Categories

  • Cardiac Research
Sponsor(s)
Abbott Vascular
Contact
Genesis Research at 563-421-3941

Location

  • Medical Center, East Rusholme Street
    1227 East Rusholme Street
    Davenport, IA 52803
    Main: 563-421-1000

Contact Us

For more information about our research program and IRB, please contact:

Research Support Office
563-421-7955

Email